The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.




Dana-Farber Cancer Institute - $50,000

Amount
$50,000.00
Date
November 2013

Phase II Trial of Molecularly Determined Treatment of Children and Young Adults with Newly Diagnosed Diffuse Intrinsic Pontine Gliomas.

Texas Children's Cancer Center - $100,000

Amount
$100,000.00
Date
November 2013

Targeting DIPGs in vivo in Intra-brain Stem Xenograft Mouse Models through Combined Radiation and Oncolytic Viral Therapy.

Children's National Medical Center - $99,979

Amount
$99,979.00
Date
November 2013

Comparative Proteomic and RNA Sequencing of DIPGs

Sydney Children's Hospital - $100,000

Amount
$100,000.00
Date
January 2013

Research of treatments for Diffuse Intrinsic Pontine Glioma (DIPG)

Stanford University Medical Center - $35,589

Amount
$35,589.00
Date
October 2012

A Combinatorial Approach to Target Cellular Subpopulations in DIPG

Texas Children's Cancer Center - $100,000

Amount
$100,000.00
Date
October 2012

Preclinical Evaluation of Novel BMI-1 Inhibitors In Vivo in Intra-Brainstem Orthotopic Xenograft Mouse Models

St. Jude's Children's Research Hospital - $15,000

Amount
$15,000.00
Date
October 2012

Establishment and Characterization of Renewable Tissue Resources for DIPG Research

DIPG Registry - $219,000

Amount
$219,000.00
Date
January 2012

Establishment of an International DIPG Registry

Texas Children's Cancer Center - $100,000

Amount
$100,000.00
Date
November 2011

Eliminating Therapy-Resistant Diffuse Intrinsic Pontine Gliomas with Oncolytic Picorna Virus SVV-001

Duke University - $82,049

Amount
$82,049.00
Date
November 2011

Preclinical Evaluation of Systemic and Direct Delivery of a PDGFR-Alpha Antibody

Doernbecher Children's Hospital - $100,000

Amount
$100,000.00
Date
November 2011

Rapid Preclinical Development of a Targeted Therapy Combination for DIPG.

Sydney Children's Hospital - $100,000

Amount
$100,000.00
Date
August 2011

Robotic screening for novel therapies for diffuse pontine gliomas

St. Jude's Children's Research Hospital - $35,000

Amount
$35,000.00
Date
September 2010

PI3K signaling effectors in DIPG

Cincinnati Children's Hospital - $35,000

Amount
$35,000.00
Date
September 2010

Establishment of a pre-clinical model for pediatric glioblastoma

Cincinnati Children's Hospital - $75,000

Amount
$75,000.00
Date
March 2010

Telomerase: A Therapeutic Target in Pediatric Brain Tumors